Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Vir Biotechnology, Inc. Common Stock (VIR)

Vir Biotechnology's stock sees a decline despite positive hepatitis treatment trial news and acquisition rumors, with Q1 2025 financial results raising concerns among investors.

### About Vir Biotechnology, Inc. Common Stock
Vir Biotechnology, Inc. is a biotechnology company focused on developing treatments for serious infectious diseases.  
Vir Biotechnology, Inc. Common Stock uses the ticker $VIR for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Vir Biotechnology, Inc. Common Stock (VIR) trading volume is up XXXXXX% from the previous week.
- Vir Biotechnology, Inc. Common Stock (VIR) market cap is up XXXXX% from the previous X months.
- Vir Biotechnology, Inc. Common Stock (VIR) sentiment is up XXXXX% from the previous week.

### Price: $XXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$vir/time-series/close.tsv)  
The stock price has declined by XXXX% in the last XX hours, driven by concerns over Q1 2025 financial results, overshadowing positive news from hepatitis treatment trials and acquisition rumors. Social media sentiment reflects cautiousness despite some speculative buying.  

24-Hour: XXXX%
7-Day: XXXXX%
30-Day: XXXXX%

1-Year High: $XXXXX on 2025-01-08  
1-Year Low: $XXXX on 2025-08-11  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$vir/time-series/alt_rank.tsv)  
Vir Biotechnology, Inc. Common Stock (VIR) is currently AltRank #1,453 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXXXX +622  
X Month: XXXXX +144  
X Months: XXXXX -X  
X Year: XXXXX +898  
1-Year High: XXXXX on 2025-09-13  
1-Year Low: XX on 2025-03-01  
  
  
### Galaxy Score: XX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$vir/time-series/galaxy_score.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -X  
X Month: XX -XX  
X Months: XX -XX  
X Year: XX -XX  
1-Year High: XX on 2025-01-21  
1-Year Low: X on 2025-07-18  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$vir/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXXX +271%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX +84%  
1-Year High: XXXXXXX on 2025-01-10  
1-Year Low: XX on 2025-10-27  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$vir/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +83%  
X Months: XXXXX -XX%  
X Year: XXXXX +157%  
1-Year High: XXXXX on 2025-01-17  
1-Year Low: X on 2025-10-28  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$vir/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Vir Biotechnology, Inc. Common Stock (VIR) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +57%  
X Months: XXXXX +78%  
X Year: XXXXX +102%  
1-Year High: XXX on 2025-01-17  
1-Year Low: X on 2025-10-28  

The most influential creators that mention Vir Biotechnology, Inc. Common Stock in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly) | X    | XX        | X     | XXX         |

[View More](/list/creators/$vir/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$vir/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% +11%  
X Month: XXX% no change  
X Months: XXX% +18%  
X Year: XXX% +48%  
1-Year High: XXX% on 2025-02-15  
1-Year Low: XX% on 2025-05-04  

Most Supportive Themes:
- Hepatitis B and D Treatment Trials: (20%) Vir Biotechnology is developing treatments for serious infectious diseases, with a focus on Hepatitis B and D.
- T-cell Engager Development: (15%) The company is also advancing its T-cell engager technology for potential therapeutic applications.
  
Most Critical Themes:
- Q1 2025 Financial Results: (40%) Vir Biotechnology, Inc. is a biotechnology company focused on developing treatments for serious infectious diseases.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$vir/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXX%  
X Week: XXXXXX% -XXXXXX%  
X Month: XXXXXX% +0.0041%  
X Months: XXXXXX% -XXXXXX%  
X Year: XXXXXX% -XXXXX%  
1-Year High: XXXXX% on 2025-01-17  
1-Year Low: XXXXXX% on 2025-10-28  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$vir/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-01-09  
1-Year Low: XXXXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$vir/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$vir/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXX  
Daily Average: $XXXXXXXXXXX  
X Week: $XXXXXXXXXXX +$20%  
X Month: $XXXXXXXXXXX +$30%  
X Months: $XXXXXXXXXXX +$28%  
X Year: $XXXXXXXXXXX -$23%  
1-Year High: $XXXXXXXXXXXXX on 2025-01-08  
1-Year Low: $XXXXXXXXXXX on 2025-08-11  

### Top Vir Biotechnology, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"  
[X Link](https://x.com/BuyTheUgly/status/1998485125680738411) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:09Z XX followers, XXX engagements


"Do we need #GLP1 bubble burst 💥 $GPCR $WVE $LLY to wide open the door for #transformative #geneTheraoy #carT curable treatments 😅 #CRISPR #baseEditing #primeEditing #carT #immunotheraoy $CRSP $BEAM $NTLA $EDIT $PRME $CRBU $QURE $SRPT $RGNX $LEGN $allo $ibrx $iova $VIR $vygr"  
[X Link](https://x.com/BRSreality/status/1998210025970442333) [@BRSreality](/creator/x/BRSreality) 2025-12-09T01:56Z XXX followers, XXX engagements


"Bairdthe PT on $MIRM to $XX from $XX reiterated at Outperform and said Raising target price to $XX on acquisition. $GILD $VIR ARWR JNJ Baird added The agreement to acquire Bluejay Therapeutics for $620M in cash/stock and up to $200M tiered sales milestones brings in a shot on goal at HDV in brelovitug. The drug has already demonstrated a XXX% HDV RNA response in Ph2 and with a Ph3 readout expected 2H26 we think this can be an approvable drug and believe the high unmet need supports the expectation for peak sales to exceed half a billion dollars annually"  
[X Link](https://x.com/Quantumup1/status/1998124188146737295) [@Quantumup1](/creator/x/Quantumup1) 2025-12-08T20:15Z 3919 followers, 1133 engagements


"Just think of what this means for realestate $Z $OPEN $COMP $REAL $SKLZ $PLTR $AI $SMR $OKLO $LEGN $VIR $CRSP $PACB $ILMN $GH $TDOC $RXRX $SDGR $VERV $PRME $LYEL $FATE $CRBU $ADPT $NTRA $EXAS $NVTA $PSNL $BNR $TWST"  
[X Link](https://x.com/mariostario2019/status/1998061041721524463) [@mariostario2019](/creator/x/mariostario2019) 2025-12-08T16:04Z XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Vir Biotechnology, Inc. Common Stock (VIR)

Vir Biotechnology's stock sees a decline despite positive hepatitis treatment trial news and acquisition rumors, with Q1 2025 financial results raising concerns among investors.

About Vir Biotechnology, Inc. Common Stock

Vir Biotechnology, Inc. is a biotechnology company focused on developing treatments for serious infectious diseases.
Vir Biotechnology, Inc. Common Stock uses the ticker $VIR for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Vir Biotechnology, Inc. Common Stock (VIR) trading volume is up XXXXXX% from the previous week.
  • Vir Biotechnology, Inc. Common Stock (VIR) market cap is up XXXXX% from the previous X months.
  • Vir Biotechnology, Inc. Common Stock (VIR) sentiment is up XXXXX% from the previous week.

Price: $XXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has declined by XXXX% in the last XX hours, driven by concerns over Q1 2025 financial results, overshadowing positive news from hepatitis treatment trials and acquisition rumors. Social media sentiment reflects cautiousness despite some speculative buying.

24-Hour: XXXX% 7-Day: XXXXX% 30-Day: XXXXX%

1-Year High: $XXXXX on 2025-01-08
1-Year Low: $XXXX on 2025-08-11

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Vir Biotechnology, Inc. Common Stock (VIR) is currently AltRank #1,453 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX +622
X Month: XXXXX +144
X Months: XXXXX -X
X Year: XXXXX +898
1-Year High: XXXXX on 2025-09-13
1-Year Low: XX on 2025-03-01

Galaxy Score: XX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-01-21
1-Year Low: X on 2025-07-18

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXXX +271%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +84%
1-Year High: XXXXXXX on 2025-01-10
1-Year Low: XX on 2025-10-27

Engagements by network (24h): X: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +83%
X Months: XXXXX -XX%
X Year: XXXXX +157%
1-Year High: XXXXX on 2025-01-17
1-Year Low: X on 2025-10-28

Mentions by network (24h): X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Vir Biotechnology, Inc. Common Stock (VIR) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XXX +57%
X Months: XXXXX +78%
X Year: XXXXX +102%
1-Year High: XXX on 2025-01-17
1-Year Low: X on 2025-10-28

The most influential creators that mention Vir Biotechnology, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@BuyTheUgly X XX X XXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +11%
X Month: XXX% no change
X Months: XXX% +18%
X Year: XXX% +48%
1-Year High: XXX% on 2025-02-15
1-Year Low: XX% on 2025-05-04

Most Supportive Themes:

  • Hepatitis B and D Treatment Trials: (20%) Vir Biotechnology is developing treatments for serious infectious diseases, with a focus on Hepatitis B and D.
  • T-cell Engager Development: (15%) The company is also advancing its T-cell engager technology for potential therapeutic applications.

Most Critical Themes:

  • Q1 2025 Financial Results: (40%) Vir Biotechnology, Inc. is a biotechnology company focused on developing treatments for serious infectious diseases.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% -XXXXXX%
X Month: XXXXXX% +0.0041%
X Months: XXXXXX% -XXXXXX%
X Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-17
1-Year Low: XXXXXX% on 2025-10-28

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-01-09
1-Year Low: XXXXXXX% on 2025-12-09

Market Cap: $XXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXX
Daily Average: $XXXXXXXXXXX
X Week: $XXXXXXXXXXX +$20%
X Month: $XXXXXXXXXXX +$30%
X Months: $XXXXXXXXXXX +$28%
X Year: $XXXXXXXXXXX -$23%
1-Year High: $XXXXXXXXXXXXX on 2025-01-08
1-Year Low: $XXXXXXXXXXX on 2025-08-11

Top Vir Biotechnology, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"
X Link @BuyTheUgly 2025-12-09T20:09Z XX followers, XXX engagements

"Do we need #GLP1 bubble burst 💥 $GPCR $WVE $LLY to wide open the door for #transformative #geneTheraoy #carT curable treatments 😅 #CRISPR #baseEditing #primeEditing #carT #immunotheraoy $CRSP $BEAM $NTLA $EDIT $PRME $CRBU $QURE $SRPT $RGNX $LEGN $allo $ibrx $iova $VIR $vygr"
X Link @BRSreality 2025-12-09T01:56Z XXX followers, XXX engagements

"Bairdthe PT on $MIRM to $XX from $XX reiterated at Outperform and said Raising target price to $XX on acquisition. $GILD $VIR ARWR JNJ Baird added The agreement to acquire Bluejay Therapeutics for $620M in cash/stock and up to $200M tiered sales milestones brings in a shot on goal at HDV in brelovitug. The drug has already demonstrated a XXX% HDV RNA response in Ph2 and with a Ph3 readout expected 2H26 we think this can be an approvable drug and believe the high unmet need supports the expectation for peak sales to exceed half a billion dollars annually"
X Link @Quantumup1 2025-12-08T20:15Z 3919 followers, 1133 engagements

"Just think of what this means for realestate $Z $OPEN $COMP $REAL $SKLZ $PLTR $AI $SMR $OKLO $LEGN $VIR $CRSP $PACB $ILMN $GH $TDOC $RXRX $SDGR $VERV $PRME $LYEL $FATE $CRBU $ADPT $NTRA $EXAS $NVTA $PSNL $BNR $TWST"
X Link @mariostario2019 2025-12-08T16:04Z XX followers, XXX engagements

Vir Biotechnology, Inc. Common Stock (VIR)
/topic/$vir